Agriculture & Biology
Actinobacillus pleuropneumoniae
88%
prototypes
64%
vaccines
54%
lesions (animal)
25%
testing
24%
Gram-negative bacteria
20%
infection
16%
pleuropneumonia
15%
swine
13%
vaccine development
13%
livestock and meat industry
12%
adjuvants
11%
antibody formation
10%
recombinant proteins
10%
vaccination
9%
serotypes
9%
cytotoxicity
9%
animals
8%
immune response
8%
pathogenicity
8%
lungs
8%
economics
7%
antibodies
7%
Medicine & Life Sciences
Actinobacillus pleuropneumoniae
100%
Vaccines
47%
Actinobacillus Infections
38%
Membranes
37%
Gram-Negative Bacteria
21%
Pleuropneumonia
17%
Swine
16%
Immunoglobulin G
16%
Vaccinology
16%
Livestock
12%
Animals
10%
Recombinant Proteins
10%
Membrane Potentials
10%
Industry
9%
Serogroup
9%
Antibody Formation
9%
Virulence
9%
Vaccination
8%
Economics
8%
Antibodies
5%
Lung
5%
Infections
5%